These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31637486)

  • 1. Overexpression of fractalkine and its histopathological characteristics in primary pterygium.
    Turan M; Turan G
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2743-2750. PubMed ID: 31637486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YKL-40 expression in pterygium: a potential role in the pathogenesis.
    Kurt A; Kılıç R; Tad M; Polat OA
    Int Ophthalmol; 2019 Jul; 39(7):1445-1450. PubMed ID: 29922975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence.
    Turan M; Turan G
    Eur J Ophthalmol; 2020 Nov; 30(6):1232-1237. PubMed ID: 32703006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of prostaglandin E
    Dinç E; Dursun Ö; Yılmaz B; Vatansever M; Sarı AA; Yıldırım Ö; Adıgüzel U
    Int Ophthalmol; 2018 Aug; 38(4):1703-1708. PubMed ID: 28695379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.
    Bianchi E; Scarinci F; Grande C; Plateroti R; Plateroti P; Plateroti AM; Fumagalli L; Capozzi P; Feher J; Artico M
    Int J Immunopathol Pharmacol; 2012; 25(3):607-15. PubMed ID: 23058011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic characterization of telocyte-like cells in pterygium.
    Maxia C; Murtas D; Isola M; Tamma R; Zucca I; Piras F; Ribatti D; Diana A; Perra MT
    Mol Vis; 2018; 24():853-866. PubMed ID: 30713424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of human cystatin C in pterygium versus healthy conjunctiva.
    Barba-Gallardo LF; Ventura-Juárez J; Kershenobich Stalnikowitz D; Gutiérrez-Campos R; Torres-Bernal E; Torres-Bernal LF
    BMC Ophthalmol; 2013 Feb; 13():6. PubMed ID: 23442876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cyclophilin A and VEGF in the pathogenesis and recurrence of pterygium.
    Turan M; Turan G; Can HY
    Eur J Ophthalmol; 2022 Sep; ():11206721221128664. PubMed ID: 36147022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor.
    Park CY; Choi JS; Lee SJ; Hwang SW; Kim EJ; Chuck RS
    Mol Vis; 2011; 17():3468-80. PubMed ID: 22219642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.
    Liang K; Jiang Z; Ding BQ; Cheng P; Huang DK; Tao LM
    Mol Vis; 2011; 17():1687-93. PubMed ID: 21738398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular surface changes in pterygium.
    Chan CM; Liu YP; Tan DT
    Cornea; 2002 Jan; 21(1):38-42. PubMed ID: 11805505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of vimentin-expressing cells in pterygium: an immunocytochemical study of impression cytology specimens.
    Chen YT; Tseng SH; Tsai YY; Huang FC; Tseng SY
    Cornea; 2009 Jun; 28(5):547-52. PubMed ID: 19421041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of pterygium surgery.
    Celeva Markovska V; Stankovic Babic G; Zdravkovska Jankuloska M
    Prilozi; 2011; 32(2):273-87. PubMed ID: 22286630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium.
    Dong Y; Kase S; Dong Z; Fukuhara J; Tagawa Y; Ishizuka ET; Murata M; Shinmei Y; Ohguchi T; Kanda A; Noda K; Ishida S
    Int J Mol Med; 2016 Aug; 38(2):545-50. PubMed ID: 27314284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of erythropoietin receptor in human pterygial tissues.
    Kase S; Osaki M; Jin XH; Ohgami K; Yoshida K; Saito W; Takahashi S; Nakanishi K; Ito H; Ohno S
    Int J Mol Med; 2007 Nov; 20(5):699-702. PubMed ID: 17912463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of endothelial RAGE expression in pterygium.
    Al-Swailem S; Xu Z; Wu L; Hartsock MJ; Yiu SC; Duh EJ
    Mol Vis; 2014; 20():1740-8. PubMed ID: 25593504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage in human pterygium: one-shot multiple targets.
    Cimpean AM; Sava MP; Raica M
    Mol Vis; 2013; 19():348-56. PubMed ID: 23401662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of c-Myc in pterygium and cultured pterygial cells.
    Cui D; Pan Z; Zhang S; Zheng J; Huang Q; Wu K
    Clin Exp Ophthalmol; 2011 Nov; 39(8):784-92. PubMed ID: 22050566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium.
    Kase S; Takahashi S; Sato I; Nakanishi K; Yoshida K; Ohno S
    Br J Ophthalmol; 2007 Jul; 91(7):958-61. PubMed ID: 17179165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of pterygium severity with IQ-domain GTPase-activating protein 1 (IQGAP1) and mast cells.
    Lai TT; Sun YC; Hsu WC; Hsieh YT; Shen EP
    Exp Eye Res; 2020 Jan; 190():107896. PubMed ID: 31836492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.